Table 3.

Subgroup analysis of patients with avid ipsilateral axillary lymph nodes post-vaccination

Weeks post-vaccination	Male	Female	P value
<6	27/78 (35%)	39/76 (51%)	0.04
≥6	3/20 (15%)	5/30 (17%)	0.88
	Aged <65 years	Aged ≥65 years
<6	29/53 (55%)	37/101 (37%)	0.03
≥6	5/13 (38.5%)	3/37 (8%)	0.01
	Pfizer-BioNTech	Oxford-AstraZeneca
<6	14/42 (33%)	19/36 (53%)	0.08
≥6	4/20 (20%)	2/7 (29%)	0.64